Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G2UY
|
|||
Former ID |
DIB002370
|
|||
Drug Name |
HBF-0259
|
|||
Synonyms |
PBHBV-001; PBHBV-2-1; PBHBV-2-15; Hepatitis B surface antigen inhibitors (oral, hepatitis B virus infection), Institute for Hepatitis & Virus Research/Enantigen Therapeutics
Click to Show/Hide
|
|||
Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Investigative | [1] | |
Company |
Institute For Hepatitis & Virus Research
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H12Cl2FN5
|
|||
Canonical SMILES |
C1C(NC2=NN=NN2C1C3=C(C=CC=C3Cl)F)C4=CC=C(C=C4)Cl
|
|||
InChI |
1S/C16H12Cl2FN5/c17-10-6-4-9(5-7-10)13-8-14(24-16(20-13)21-22-23-24)15-11(18)2-1-3-12(15)19/h1-7,13-14H,8H2,(H,20,21,23)
|
|||
InChIKey |
BRBZPYDLUUWBCD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.